Retention rates high after biosimilar-to-biosimilar switch for inflammatory arthritisNovember 14, 2022Psoriatic Arthritis
Commentary: Drug efficacy and comorbid factors in PsA, November 2022October 29, 2022Psoriatic Arthritis
Two biologics equally effective for extraintestinal manifestations of IBDOctober 27, 2022Psoriatic Arthritis
IgA Vasculitis in the Setting of Biologic Therapy for Psoriasis and Recurrent Cutaneous Methicillin-Resistant Staphylococcus aureus ColonizationOctober 26, 2022Psoriatic Arthritis
bDMARDs, especially anti-TNF agents, reduce radiographic progression in PsAOctober 25, 2022Psoriatic Arthritis
PsA: Meta-analysis demonstrates low rate of opportunistic infections with bDMARDs and tsDMARDsOctober 25, 2022Psoriatic Arthritis
Meta-analysis demonstrates efficacy of JAK inhibitors in treating PsAOctober 25, 2022Psoriatic Arthritis
PsA: Tofacitinib reduces pain by improving itch and other symptomsOctober 25, 2022Psoriatic Arthritis
